AI made execution free. Knowing first is the whole game now.
The advantage goes to whoever is first into the right conversations, most often. Fundz stacks those odds: more of the moments that create demand than anyone else catches, as they happen, matched to who you sell to, with the decision maker to call. Now it answers in Claude too: ask for today’s leads and who to reach, then write the note in the same window. Not a feed. Not a list you rent. A system for being first.
Trusted by
Acquiring Company
EPIX
Acquired Company
ESSA Pharma
North Brabant
South San FranciscoBiotechnologyHealth CareBiotechnologyHealth CareMedicalTherapeuticsPharmaceuticalDescription
EPIX has finalized a merger agreement with ESSA Pharma, changing the terms for shareholders. Each ESSA Pharma share will convert to a combination of cash and EPIX shares. This merger enhances EPIX's capabilities in oncology-focused drug development. The transaction reflects a strategic move to strengthen the market position in biopharmaceuticals.
Fundz sees it the moment EPIX makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired ESSA Pharma?
ESSA Pharma was acquired by EPIX, based in North Brabant. The deal was reported on September 24, 2026. EPIX is the successor entity in a merger with ESSA Pharma. The company operates in the biotech industry with a focus on oncology. Through this merger, EPIX aims to enhance its portfolio of cancer therapies. EPIX is privately held and operates in Biotechnology.
When did EPIX acquire ESSA Pharma?
EPIX's acquisition of ESSA Pharma was reported on September 24, 2026. EPIX has finalized a merger agreement with ESSA Pharma, changing the terms for shareholders. Each ESSA Pharma share will convert to a combination of cash and EPIX shares. This merger enhances EPIX's capabilities in oncology-focused drug development. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does ESSA Pharma do?
ESSA is a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer. It is privately held, operating in Biotechnology, and is based in South San Francisco.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.
5 screens from a live account. No signup.